Alcon Inc. (ALC) Balance Sheet

The balance sheet has expanded modestly, with total assets increasing by approximately 5% since 2024Q1, driven largely by a rise in goodwill and PPE. This suggests continued investment in growth, but the stable leverage ratio implies the expansion is not debt-fueled. The consistent equity growth, from $20.8B to $21.6B, reflects retained earnings accumulation, though reported retained earnings are zero, indicating that equity growth may be driven by other comprehensive income or capital transactions.

Alcon's debt levels have been remarkably stable, hovering near $5.2B, and the D/E ratio of 0.24 is low compared to the peer group, indicating ample financial flexibility. The stability of debt suggests that the company is not aggressively leveraging to fund operations or acquisitions, which may reflect a disciplined capital allocation approach. However, the absolute debt amount is significant, and investors should monitor interest coverage, especially given the recent operating margin volatility.

The substantial goodwill, which has grown from $8.9B to $9.3B, likely stems from the Novartis spin-off and the Aerie acquisition, and it represents a large portion of the asset base. This raises impairment risk if future cash flows underperform. In contrast, PPE is relatively modest, suggesting a manufacturing model that relies on specialized but not overly capital-intensive facilities. The increasing PPE trend, from $4.7B to $5.3B, indicates ongoing investment in production capacity, which may support margin expansion if utilization improves.

The absence of retained earnings in the data is notable, but the steady increase in equity suggests that the company is generating profits that are being reinvested or held in other equity components. Given the prior cash flow analysis showing cumulative net income of $2.2B, it is likely that retained earnings are being offset by dividends or other distributions, or the data may be incomplete. The consistent equity growth provides a cushion for creditors and indicates a healthy balance sheet, though the lack of transparency on retained earnings warrants further investigation.

The current ratio, while declining from 2.77 in 2024Q4 to 2.09 in 2026Q2, remains above 2, suggesting that Alcon can comfortably cover short-term obligations. Cash levels have fluctuated between $1.1B and $1.7B, providing a buffer against operational shocks. However, the downward trend in the current ratio may indicate that current liabilities are growing faster than current assets, possibly due to increased payables or short-term debt. Given the stable cash flow generation, liquidity risk appears low, but the trend warrants monitoring.